Hongfu Wu

Nucleostemin Modulates Outcomes of Hepatocellular Carcinoma via a Tumor Adaptive Mechanism to Genomic Stress

Shiaw-Yih Lin, Junying Wang, M. Finegold, 2020, Molecular Cancer Research.

Tislelizumab uniquely binds to the CC′ loop of PD‐1 with slow‐dissociated rate and complete PD‐L1 blockage

Xiaomin Song, Tong Zhang, Yucheng Li, 2021, FEBS open bio.

Crystal structure of Bacillus thuringiensis Cry8Ea1: An insecticidal toxin toxic to underground pests, the larvae of Holotrichia parallela.

Z. Rao, Lei Wei, S. Ye, 2009, Journal of structural biology.

Abstract 2383: The molecular binding mechanism of tislelizumab, an investigational anti-PD-1 antibody, is differentiated from pembrolizumab and nivolumab

X. Liu, Hanzi Sun, Yuan Hong, 2019, Immunology.